Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial

Helge Bischoff; Caicun Zhou; Fumio Imarnura; Ying Cheng; Isamu Okamoto; Byoung Chul Cho; Meng-Chih Lin; Margarita Majem; Oliver Gautschi; Jhanelle Elaine Gray; Michael J. Boyer; Juliann Chmielecki; Ryan Hartmaier; Krishna Bulusu; J. Carl Barrett; Rachel Hodge; Matilde Saggese; Astrid Mckeown; Suresh S. Ramalingam; Niels Reinmuth

Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial

Helge Bischoff, Caicun Zhou, Fumio Imarnura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Oliver Gautschi, Jhanelle Elaine Gray, Michael J. Boyer, Juliann Chmielecki, Ryan Hartmaier, Krishna Bulusu, J. Carl Barrett, Rachel Hodge, Matilde Saggese, Astrid Mckeown, Suresh S. Ramalingam, Niels Reinmuth

School of Traditional Chinese Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Pages (from-to)	122-122
Journal	ONCOLOGY RESEARCH AND TREATMENT
Volume	43
State	Published - 2020

Cite this

Bischoff, H., Zhou, C., Imarnura, F., Cheng, Y., Okamoto, I., Cho, B. C., Lin, M.-C., Majem, M., Gautschi, O., Gray, J. E., Boyer, M. J., Chmielecki, J., Hartmaier, R., Bulusu, K., Barrett, J. C., Hodge, R., Saggese, M., Mckeown, A., Ramalingam, S. S., & Reinmuth, N. (2020). Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial. ONCOLOGY RESEARCH AND TREATMENT, 43, 122-122.

@article{9175214267544750bdfc86289b1b8402,

title = "Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial",

author = "Helge Bischoff and Caicun Zhou and Fumio Imarnura and Ying Cheng and Isamu Okamoto and Cho, {Byoung Chul} and Meng-Chih Lin and Margarita Majem and Oliver Gautschi and Gray, {Jhanelle Elaine} and Boyer, {Michael J.} and Juliann Chmielecki and Ryan Hartmaier and Krishna Bulusu and Barrett, {J. Carl} and Rachel Hodge and Matilde Saggese and Astrid Mckeown and Ramalingam, {Suresh S.} and Niels Reinmuth",

year = "2020",

language = "American English",

volume = "43",

pages = "122--122",

journal = "ONCOLOGY RESEARCH AND TREATMENT",

issn = "2296-5270",

publisher = "S. Karger AG",

}

Bischoff, H, Zhou, C, Imarnura, F, Cheng, Y, Okamoto, I, Cho, BC, Lin, M-C, Majem, M, Gautschi, O, Gray, JE, Boyer, MJ, Chmielecki, J, Hartmaier, R, Bulusu, K, Barrett, JC, Hodge, R, Saggese, M, Mckeown, A, Ramalingam, SS & Reinmuth, N 2020, 'Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial', ONCOLOGY RESEARCH AND TREATMENT, vol. 43, pp. 122-122.

TY - JOUR

T1 - Early Clearance of Plasma EGFR Mutations As a Predictor of Response to Osimertinib and Comparator EGFR-TKiS in the Flaura Trial

AU - Bischoff, Helge

AU - Zhou, Caicun

AU - Imarnura, Fumio

AU - Cheng, Ying

AU - Okamoto, Isamu

AU - Cho, Byoung Chul

AU - Lin, Meng-Chih

AU - Majem, Margarita

AU - Gautschi, Oliver

AU - Gray, Jhanelle Elaine

AU - Boyer, Michael J.

AU - Chmielecki, Juliann

AU - Hartmaier, Ryan

AU - Bulusu, Krishna

AU - Barrett, J. Carl

AU - Hodge, Rachel

AU - Saggese, Matilde

AU - Mckeown, Astrid

AU - Ramalingam, Suresh S.

AU - Reinmuth, Niels

PY - 2020

Y1 - 2020

M3 - Journal Article

SN - 2296-5270

VL - 43

SP - 122

EP - 122

JO - ONCOLOGY RESEARCH AND TREATMENT

JF - ONCOLOGY RESEARCH AND TREATMENT

ER -